GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Read-Gene SA (WAR:RDG) » Definitions » Cash Flow from Others

Read-Gene (WAR:RDG) Cash Flow from Others

: zł0.33 Mil (TTM As of Sep. 2023)
View and export this data going back to 2009. Start your Free Trial

Read-Gene's cash flow from others for the three months ended in Sep. 2023 was zł-0.02 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Sep. 2023 was zł0.33 Mil.


Read-Gene Cash Flow from Others Historical Data

The historical data trend for Read-Gene's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Read-Gene Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cash Flow from Others
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.71 -2.65 0.28 1.07 0.35

Read-Gene Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cash Flow from Others Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.35 - - -0.02

Read-Gene Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.33 Mil.

Read-Gene Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Read-Gene's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Read-Gene (WAR:RDG) Business Description

Traded in Other Exchanges
N/A
Address
Ulica Alabastrowa 8, Grzepnica, Dobra, POL, 72-003
Read-Gene SA treats each patient individually based on genetic tests. The company's segments include chemoprevention, clinical trials and genetic tests. It also engaged in developing technologies to commercialize methods to detect, prevent and treat malignant tumours.

Read-Gene (WAR:RDG) Headlines

No Headlines